These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37834182)

  • 61. CD56
    Ma M; Yin X; Zhao X; Guo C; Zhu X; Liu T; Yang M; Zhang Z; Fu Y; Liu J; Xu J; Ding H; Han X; Chu Z; Shang H; Jiang Y
    J Leukoc Biol; 2019 Dec; 106(6):1313-1323. PubMed ID: 31483071
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.
    Nielsen N; Ødum N; Ursø B; Lanier LL; Spee P
    PLoS One; 2012; 7(2):e31959. PubMed ID: 22384114
    [TBL] [Abstract][Full Text] [Related]  

  • 63. NKG2D functions as an activating receptor on natural killer cells in the common marmoset (Callithrix jacchus).
    Watanabe M; Kudo Y; Kawano M; Nakayama M; Nakamura K; Kameda M; Ebara M; Sato T; Nakamura M; Omine K; Kametani Y; Suzuki R; Ogasawara K
    Int Immunol; 2014 Nov; 26(11):597-606. PubMed ID: 24860119
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dysfunction of natural killer cells mediated by PD-1 and Tim-3 pathway in anaplastic thyroid cancer.
    Yin M; Di G; Bian M
    Int Immunopharmacol; 2018 Nov; 64():333-339. PubMed ID: 30243069
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The two-pore domain K2 P channel TASK2 drives human NK-cell proliferation and cytolytic function.
    Schulte-Mecklenbeck A; Bittner S; Ehling P; Döring F; Wischmeyer E; Breuer J; Herrmann AM; Wiendl H; Meuth SG; Gross CC
    Eur J Immunol; 2015 Sep; 45(9):2602-14. PubMed ID: 26140335
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer.
    Gogali F; Paterakis G; Rassidakis GZ; Liakou CI; Liapi C
    Thyroid; 2013 Dec; 23(12):1561-8. PubMed ID: 23721357
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regulation of human NK-cell cytokine and chemokine production by target cell recognition.
    Fauriat C; Long EO; Ljunggren HG; Bryceson YT
    Blood; 2010 Mar; 115(11):2167-76. PubMed ID: 19965656
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low-frequency, exhausted immune status of CD56
    Pan Z; Zhao R; Shen Y; Liu K; Xue W; Liang C; Peng M; Hu P; Chen M; Xu H
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108369. PubMed ID: 34844872
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The CD56-CD16+ NK cell subset in chronic infections.
    Cocker ATH; Guethlein LA; Parham P
    Biochem Soc Trans; 2023 Jun; 51(3):1201-1212. PubMed ID: 37140380
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
    Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
    AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increased ILT2 expression contributes to dysfunction of CD56
    Zhang Y; Tong S; Li S; Wang X; Ren H; Yin W
    Antiviral Res; 2022 Sep; 205():105385. PubMed ID: 35917968
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.
    Ndhlovu LC; Lopez-Vergès S; Barbour JD; Jones RB; Jha AR; Long BR; Schoeffler EC; Fujita T; Nixon DF; Lanier LL
    Blood; 2012 Apr; 119(16):3734-43. PubMed ID: 22383801
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines.
    Sivori S; Parolini S; Marcenaro E; Castriconi R; Pende D; Millo R; Moretta A
    J Neuroimmunol; 2000 Jul; 107(2):220-5. PubMed ID: 10854660
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gradual Increase of FcγRIIIa/CD16a Expression and Shift toward IFN-γ Secretion during Differentiation of CD56
    Lajoie L; Congy-Jolivet N; Bolzec A; Thibault G
    Front Immunol; 2017; 8():1556. PubMed ID: 29209315
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant.
    Zhu L; Aly M; Wang H; Karakizlis H; Weimer R; Morath C; Kuon RJ; Toth B; Ekpoom N; Opelz G; Daniel V
    Clin Exp Immunol; 2018 Aug; 193(2):241-254. PubMed ID: 29679490
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Glycodelin-A stimulates the conversion of human peripheral blood CD16-CD56bright NK cell to a decidual NK cell-like phenotype.
    Lee CL; Vijayan M; Wang X; Lam KKW; Koistinen H; Seppala M; Li RHW; Ng EHY; Yeung WSB; Chiu PCN
    Hum Reprod; 2019 Apr; 34(4):689-701. PubMed ID: 30597092
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nasal lavage natural killer cell function is suppressed in smokers after live attenuated influenza virus.
    Horvath KM; Herbst M; Zhou H; Zhang H; Noah TL; Jaspers I
    Respir Res; 2011 Aug; 12(1):102. PubMed ID: 21816072
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The Expression and Function of NK Cells in Patients with Acute Myeloid Leukemia].
    Liu L; Chen X; Jin HM; Zhao SS; Zhu Y; Qian SX; Wu YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):49-55. PubMed ID: 35123603
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dysfunction of CD3
    Tahrali I; Kucuksezer UC; Altintas A; Uygunoglu U; Akdeniz N; Aktas-Cetin E; Deniz G
    Clin Immunol; 2018 Aug; 193():88-97. PubMed ID: 29448007
    [No Abstract]   [Full Text] [Related]  

  • 80. Poorly cytotoxic terminally differentiated CD56
    Forconi CS; Cosgrove CP; Saikumar-Lakshmi P; Nixon CE; Foley J; Ong'echa JM; Otieno JA; Alter G; Münz C; Moormann AM
    Blood Adv; 2018 May; 2(10):1101-1114. PubMed ID: 29764843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.